Tag: prevention

On July 15, a landmark coalition of 38 professional medical, patient advocacy, and research organizations, led by the Endocrine Society, the Society for Women’s Health Research (SWHR), the American College of Obstetricians and Gynecologists (ACOG), and the Women First Research Coalition (WFRC), converged in Washington, D.C., to unveil a comprehensive National Strategy to Close the…

On July 14, the Centers for Medicare & Medicaid Services (CMS) officially released the proposed rule for the Calendar Year (CY) 2027 Medicare Physician Fee Schedule (MPFS), signaling a significant shift in how the federal government intends to reimburse healthcare providers for the coming fiscal period. The release of the 2027 proposal comes at a…

The Intersection of Hypercortisolism and Metabolic Disease Endogenous Cushing’s syndrome is a rare and complex endocrine disorder characterized by the chronic overproduction of cortisol, the body’s primary stress hormone. This condition typically stems from a pituitary tumor (Cushing’s disease), an adrenal tumor, or, more rarely, ectopic ACTH production. The systemic effects of prolonged hypercortisolism are…

The medical community has long debated the efficacy of testosterone replacement therapy (TRT) as a potential tool for managing metabolic disorders in aging men. New findings presented at the ENDO 2026 conference by Gary Wittert, MBBch, MD, have provided critical clarity on this issue, suggesting that while testosterone can indeed improve body composition, glucose metabolism,…

Ascendis Pharma A/S, a biopharmaceutical company headquartered in Copenhagen, Denmark, recently announced significant clinical and commercial updates regarding its therapeutic pipeline for achondroplasia. The most prominent update centers on the 78-week results of the Phase 2 COACH trial, which evaluates a combination therapy involving once-weekly TransCon CNP (navepegritide) and once-weekly TransCon hGH (lonapegsomatropin). In addition…

Following the conclusion of ENDO 2026 in Chicago, Illinois, the Endocrine Society has pivoted its focus toward a robust autumn schedule designed to address the evolving needs of both the global research community and clinical practitioners. This transition marks a critical period in the Society’s annual cycle, moving from the broad, multi-disciplinary scope of its…

The integration of artificial intelligence into clinical practice has transitioned from a speculative future to a tangible necessity, a shift that took center stage during the ENDO 2026 annual meeting. In a high-capacity session held on Saturday, June 13, researchers and clinicians gathered to dissect the evolving role of AI in endocrinology. The session, titled…

The landscape of endocrine research is undergoing a transformative shift as early-career scientists introduce novel perspectives on metabolic regulation, particularly through the lens of the nervous system. At the ENDO 2026 annual meeting in Chicago, the Endocrine Society highlighted this burgeoning talent through its flagship "Rising Star Power Talks," a high-stakes research communication competition. Among…

The Clinical Challenge of Post-Bariatric Hypoglycemia Post-bariatric hypoglycemia is a chronic and often debilitating metabolic complication that arises in a subset of patients who have undergone gastric bypass surgery. While bariatric procedures are highly effective at inducing weight loss and resolving type 2 diabetes, they significantly alter the anatomy and physiology of the gastrointestinal tract.…

The Pathophysiology of Acromegaly Acromegaly is a chronic and progressive condition primarily caused by a benign tumor, or adenoma, located on the pituitary gland. This tumor triggers the excessive secretion of growth hormone (GH), which in turn stimulates the liver to produce elevated levels of insulin-like growth factor 1 (IGF-I). Together, this hormonal surge drives…